In Taek Song

Title: In Taek Song: Innovator in Protein Conjugation Technology.

Introduction

In Taek Song is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the area of protein conjugation. His innovative work has led to advancements that enhance the efficacy and stability of protein drugs.

Latest Patents

In Taek Song holds a patent for a "Conjugate of catechol-modified polyethylene glycol with protein or peptide and preparation method thereof." This invention relates to a conjugate of a protein or peptide with a polyethylene glycol derivative that has catechol. The method allows for site-specific conjugation with the N-terminal amine group of a protein or peptide, resulting in a homogeneous conjugate with high yield. This innovative approach minimizes the decrease in protein activity without chemical modification, leading to improved pharmacological effects. The conjugate also demonstrates uniform biological efficacy in vivo and exhibits strong resistance to hydrolysis, thereby extending its duration in the body.

Career Highlights

In Taek Song has worked with notable institutions such as the Korea Advanced Institute of Science and Technology and Innotherapy Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

In Taek Song has collaborated with colleagues such as Haeshin Lee and Hyukjin Lee. Their joint efforts have furthered research and development in protein conjugation technologies.

Conclusion

In Taek Song's innovative contributions to protein conjugation technology have the potential to significantly impact the pharmaceutical industry. His work exemplifies the importance of advancements in biotechnology for improving drug efficacy and stability.